Outgoing Moderna CMO Lands Seat on Teva Pharmaceuticals Board of Directors | BioSpace
Teva Pharm expects U.S. opioid case settlements to cost $2.6 bln | Reuters
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State - CNN
US states sue Teva for price-fixing in 'multi-billion dollar fraud' | The Times of Israel
Teva Abandons Search to Make Covid-19 Vaccine for Partners - Bloomberg
Teva Pharmaceutical Industries (TEVA) Stock Price, News & Info | The Motley Fool
Teva Pharmaceuticals Slides After Receiving FDA Complete Response Letter By Investing.com
Rhode Island takes Teva to trial in multibillion-dollar opioid case | Reuters
/cloudfront-us-east-1.images.arcpublishing.com/gray/5ORNVHIZ6FHUHL74IGLVZ6RU4Q.jpg "New York jury holds drug firm Teva liable in opioid crisis")
New York jury holds drug firm Teva liable in opioid crisis
Teva sees higher margins, lower debt from restructuring | Financial Times
US accuses Teva of illegally fixing prices of drugs - Taipei Times
Teva Pharmaceuticals: Israeli drugmaker to cut 14,000 jobs - BBC News
Teva Pharmaceuticals has acquired success with Actavis Generics | World Finance
Roche Pharma China partners with Teva Pharmaceuticals to improve lymphoma treatments - Chinadaily.com.cn
Here's Why Teva Pharma Stock Is Soaring Today
Israel's Teva gives upbeat outlook as restructuring proceeds
TEVA: Can Teva Pharmaceutical Stock Continue to Rebound in 2021?
Teva Pharmaceuticals - Wikiwand
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
Buy Teva Pharmaceuticals amid positive news, Bernstein says
Teva Stock Skids As First-Quarter Sales Decline — Again | Investor's Business Daily
Transitioning Teva revamps branding to emphasize brand-generic unity | Fierce Pharma
Teva Pharmaceuticals - Wikiwand
Jerusalem, Israel. 21st Oct, 2019. The Teva Pharmaceutical logo is seen in English and Hebrew at their tablet production plant in Jerusalem, on Monday, October 21, 2019. The Israeli drug manufacturer Teva's
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
